Read more
XTB Online Trading

MorphoSys gains 37% amid rumours of possible takeover by Novartis

5:19 PM 5 February 2024

Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.

The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.

MorphoSys shares are currently gaining nearly 37%.

Source: xStation

Share:
Back

Market News

16.06.2025
19:02

Daily summary: Wall Street climbs, oil drops on Middle East war cool-off hopes

Despite serious military escalation between Iran and Israel over the weekend, global stock markets are rising today, as Wall Street is pricing in low...

 18:43

VIX drops 6% on stock market optimism and falling oil prices 📉

Futures on CBOE Volatility Index (VIX) loses more than 6% today as S&P 500 gains more than 1% and Nasdaq 100 surges 1.2% signalling strong risk appetite,...

 18:23

Circle Internet Group climbs to new ATH on CEO's latest comments 📈

Over the weekend, the CEO of Circle Internet Group (CRCL.US) published a post about stablecoins, indicating that this technology is currently on the cusp...
More news

Join over 1 600 000 XTB Group Clients from around the world

Start trading Download the app Download the app
The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits